Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation
暂无分享,去创建一个
[1] W. L. Benedict,et al. Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.
[2] Y. Okuda,et al. The activation of memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis , 2005, Journal of the Neurological Sciences.
[3] G. Rice,et al. Interferon β-1a in MS , 2005, Neurology.
[4] T. Tabira,et al. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.
[5] M. Kamoun,et al. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis , 2005, Journal of the Neurological Sciences.
[6] H. Panitch. Influence of infection on exacerbations of multiple sclerosis , 2004, Annals of neurology.
[7] K. Vandenbroeck,et al. Inhibiting cytokines of the interleukin‐12 family: recent advances and novel challenges , 2004, The Journal of pharmacy and pharmacology.
[8] J. Newcombe,et al. Accumulation of Vα7.2–Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system , 2004 .
[9] R. Fujinami,et al. Microorganisms and autoimmunity: making the barren field fertile? , 2003, Nature Reviews Microbiology.
[10] R. Hurren,et al. Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells 1 , 2003, The Journal of Immunology.
[11] M. Kamoun,et al. Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-β2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System1 , 2003, The Journal of Immunology.
[12] R. Kastelein,et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.
[13] T. Yamamura,et al. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. , 2003, International immunology.
[14] C. R. Lankford,et al. A unique role for IL‐23 in promoting cellular immunity , 2003, Journal of leukocyte biology.
[15] M. Kamoun,et al. IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune Demyelination1 , 2002, The Journal of Immunology.
[16] Arne Svejgaard,et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.
[17] B. Becher,et al. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. , 2002, The Journal of clinical investigation.
[18] R. Welsh,et al. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens , 2002, Nature Immunology.
[19] J. Libbey,et al. Are virus infections triggers for autoimmune disease? , 2002, Clinical Microbiology Newsletter.
[20] A. Fraire,et al. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung , 2001, Nature Immunology.
[21] T. Yamamura,et al. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.
[22] M. Ruzek,et al. NK cell functions restrain T cell responses during viral infections , 2001, European journal of immunology.
[23] M. V. von Herrath,et al. Is activation of autoreactive lymphocytes always detrimental? Viral infections and regulatory circuits in autoimmunity. , 2001, Current directions in autoimmunity.
[24] G. Giaccone,et al. Circulating Vα24+ Vβ11+ NKT Cell Numbers Are Decreased in a Wide Variety of Diseases That Are Characterized by Autoreactive Tissue Damage , 2001 .
[25] T. Sumida,et al. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. , 2001, Arthritis and rheumatism.
[26] B. Rouse,et al. Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis , 2001, Journal of Virology.
[27] R. Welsh. Assessing Cd8 T Cell Number and Dysfunction in the Presence of Antigen , 2001, The Journal of experimental medicine.
[28] T. Yamamura,et al. Natural killer type 2 bias in remission of multiple sclerosis. , 2001, The Journal of clinical investigation.
[29] B. Hilliard,et al. Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[30] M. Smyth,et al. NKT cells: facts, functions and fallacies. , 2000, Immunology today.
[31] S. Akira,et al. IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 , 2000, The Journal of Immunology.
[32] H. Link,et al. Multiple sclerosis: Pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-β , 2000, Journal of Neuroimmunology.
[33] R. Welsh,et al. Evolution of the CD8 T-cell repertoire during infections. , 2000, Microbes and infection.
[34] W. Brück,et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.
[35] A. Stalder,et al. Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis1 , 2000, The Journal of Immunology.
[36] R. Welsh,et al. Consequences of cross-reactive and bystander CTL responses during viral infections. , 2000, Virology.
[37] J. Newcombe,et al. Differential Expression of NK T Cell Vα24JαQ Invariant TCR Chain in the Lesions of Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy1 , 2000, The Journal of Immunology.
[38] P. Gallo,et al. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-b1a. , 2000 .
[39] F. Spertini,et al. Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers , 1999, Journal of Neuroimmunology.
[40] R. Fujinami,et al. Exacerbation of Viral and Autoimmune Animal Models for Multiple Sclerosis by Bacterial DNA , 1999, Brain pathology.
[41] R. Fujinami,et al. Infection with a recombinant vaccinia virus encoding myelin proteolipid protein causes suppression of chronic relapsing–remitting experimental allergic encephalomyelitis , 1999, Journal of Neuroimmunology.
[42] C. Karp. Measles: immunosuppression, interleukin‐12. and complement receptors , 1999, Immunological reviews.
[43] A. al‐Sabbagh,et al. Interferon beta modulates experimental autoimmune encephalomyelitis by altering the pattern of cytokine secretion. , 1999, Immunological investigations.
[44] S. Varga,et al. Protective Heterologous Antiviral Immunity and Enhanced Immunopathogenesis Mediated by Memory T Cell Populations , 1998, The Journal of experimental medicine.
[45] G. Trinchieri,et al. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.
[46] C. Biron. Role of early cytokines, including alpha and beta interferons (IFN-α\β), in innate and adaptive immune responses to viral infections☆ , 1998 .
[47] S. Sriram,et al. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-1-mediated Th1 differentiation; an effect of the novel anti-inflammatory drug lisofylline , 1998, Journal of Neuroimmunology.
[48] D. Paty,et al. A role for natural killer cells in the immunopathogenesis of multiple sclerosis , 1998, Journal of Neuroimmunology.
[49] G. Trinchieri,et al. Role of Interleukin-12 in Primary Influenza Virus Infection , 1998, Journal of Virology.
[50] L. Blumhardt,et al. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis , 1998, Journal of neurology, neurosurgery, and psychiatry.
[51] J. Papadimitriou,et al. Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross‐react with virus and cardiac myosin , 1998, Immunology.
[52] M. Laurent. Bistability and the species barrier in prion diseases: stepping across the threshold or not. , 1998, Biophysical chemistry.
[53] A. Cunningham,et al. In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? , 1998, The Journal of infectious diseases.
[54] D. Hafler,et al. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.
[55] M. V. von Herrath,et al. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. , 1997, Journal of autoimmunity.
[56] S. Szabo,et al. Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 Cells , 1997, The Journal of experimental medicine.
[57] M. V. von Herrath,et al. Interferon-γ Is Essential for Destruction of β Cells and Development of Insulin-dependent Diabetes Mellitus , 1997, The Journal of experimental medicine.
[58] J. Orange,et al. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection , 1997 .
[59] Richard G Richards. Interferon beta in multiple sclerosis , 1996, BMJ.
[60] B. Arnason. Interferon beta in multiple sclerosis. , 1996, Neurology.
[61] J. Orange,et al. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. , 1996, Journal of immunology.
[62] G. Marshall,et al. Interferon-beta sub 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis , 1996, Neurology.
[63] R. Fujinami,et al. Two Models for Multiple Sclerosis: Experimental Allergic Encephalomyelitis and Theiler's Murine Encephalomyelitis Virus , 1996, Journal of neuropathology and experimental neurology.
[64] B. Weinshenker,et al. Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.
[65] D. Carvajal,et al. IL-12-Deficient Mice Are Defective in IFNγ Production and Type 1 Cytokine Responses , 1996 .
[66] R. Flavell,et al. Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. , 1995, Immunity.
[67] Meijuan Zhao,et al. Interferon-γ-Induced Oligodendrocyte Cell Death: Implications for the Pathogenesis of Multiple Sclerosis , 1995, Molecular medicine.
[68] J. Orange,et al. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration , 1995, The Journal of experimental medicine.
[69] J. Frelinger,et al. Natural killer cell activity in lymphocytic choriomeningitis virus-infected beta 2-microglobulin-deficient mice. , 1995, International immunology.
[70] T. Sumida,et al. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis , 1995, The Journal of experimental medicine.
[71] J. Leonard,et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12 , 1995, The Journal of experimental medicine.
[72] D. Miller,et al. The British Isles survey of multiple sclerosis in twins , 1994, Neurology.
[73] P. Allen,et al. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. , 1993, Immunology today.
[74] A. Sher,et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[75] L. Steinman,et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.
[76] Kenneth M. Murphy,et al. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent , 1993 .
[77] T. Bergström,et al. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.
[78] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[79] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[80] D. Paty,et al. A population‐based study of multiple sclerosis in twins: Update , 1993 .
[81] E. D. Robinson,et al. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. , 1992, Journal of immunology.
[82] W. Reed,et al. Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. , 1992, Immunology.
[83] M. Nerenberg,et al. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune response , 1991, Cell.
[84] L. Kappos,et al. Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.
[85] Hiroshi Sato,et al. Theiler's murine encephalomyelitis virus--characterization of newly isolated viruses from Japanese mouse colonies. , 1990, Jikken dobutsu. Experimental animals.
[86] T. Olsson,et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.
[87] Eric O Long,et al. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.
[88] R. Fujinami,et al. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.
[89] J. Seidman,et al. Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. , 1990, Science.
[90] D. Bourdette,et al. Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.
[91] R. Fujinami,et al. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures , 1988, Journal of Neuroimmunology.
[92] H. Kirchner,et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.
[93] P. Lebon,et al. Multiple sclerosis: Involvement of interferons in lesion pathogenesis , 1988, Annals of neurology.
[94] K. Johnson. Treatment of multiple sclerosis with various interferons: The cons , 1988, Neurology.
[95] Johnson Kp. Treatment of multiple sclerosis with various interferons: the cons. , 1988 .
[96] R. Hirsch,et al. EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON , 1987, The Lancet.
[97] D. Paty,et al. A population-based study of multiple sclerosis in twins. , 1986, The New England journal of medicine.
[98] R. Fujinami,et al. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.
[99] R. Hirsch,et al. Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2 , 1985 .
[100] A. Alpérovitch,et al. CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.
[101] R. Hirsch,et al. The effect of recombinant alpha2‐interferon on defective natural killer cell activity in multiple sclerosis , 1985, Neurology.
[102] D. McFarlin,et al. Expansion of antigen-specific T cells from cerebrospinal fluid of patients with multiple sclerosis , 1983, Journal of Neuroimmunology.
[103] B. Zweiman,et al. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. , 1983, Cellular immunology.
[104] T. Merigan,et al. Natural killer cells activity in patients with multiple sclerosis given α interferon , 1983 .
[105] R. Fujinami,et al. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[106] H T Mount,et al. Multiple sclerosis and other demyelinating diseases. , 1973, Canadian Medical Association journal.
[107] R. Fujinami,et al. TMEV and Neuroantigens: Myelin Genes and Proteins, Molecular Mimicry, Epitope Spreading, and Autoantibody-Mediated Remyelination , 2005, Experimental Models of Multiple Sclerosis.
[108] M. V. von Herrath. Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. , 2002, Current topics in microbiology and immunology.
[109] M. Herrath. Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. , 2002 .
[110] H. McFarland,et al. Immunopathogenesis of the multiple sclerosis lesion , 2001, Current neurology and neuroscience reports.
[111] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[112] J. Altman,et al. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection. , 1998, Advances in experimental medicine and biology.
[113] M. Ruzek,et al. Early cytokine responses to viral infections and their roles in shaping endogenous cellular immunity. , 1998, Advances in experimental medicine and biology.
[114] M. Oldstone,et al. Interferon-g Is Essential for Destruction of b Cells and Development of Insulin-dependent Diabetes Mellitus , 1997 .
[115] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[116] Henry F. McFarland,et al. Multiple sclerosis : clinical and pathogenetic basis , 1997 .
[117] M. V. von Herrath,et al. Virus-induced autoimmune disease: transgenic approach to mimic insulin-dependent diabetes mellitus and multiple sclerosis. , 1996, Current topics in microbiology and immunology.
[118] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[119] R. Sobel. T-lymphocyte subsets in the multiple sclerosis lesion. , 1989, Research in immunology.
[120] L. Liversedge. Treatment and management of multiple sclerosis. , 1977, British medical bulletin.
[121] J. Kurtzke. Epidemiology in multiple sclerosis. , 1965, Transactions of the American Neurological Association.